SPAHP Faculty, School News
SPAHP Faculty, School News
Zara Risoldi Cochrane, PharmD, MS, FASCPZara Risoldi Cochrane, PharmD, MS, FASCP, director of the Distance Pharmacy Pathway and associate director in the Center for Drug Information & Evidence-Based Practice recently was appointed to the Board of  the Nebraska Distance Learning Association.
Maryann Skrabal, PharmD, CDEMaryann Skrabal, PharmD, CDE, associate professor of pharmacy practice and director of the office of Experiential Education was elected to the American Association of Colleges of Pharmacy (AACP) Experiential Education Section Chair and will be installed at the AACP annual meeting in July 2017. 
Amy Haddad, PhD, RN'75Amy Haddad, PhD, RN’75, professor of pharmacy sciences is a 2016 recipient of the Dr. George F. Haddix President’s Faculty Research Fund, which supports the research and scholarly productivity of full-time faculty. Haddad’s research is titled, “Collaborating with Health Professions Students to Establish Best Practices in Interdisciplinary Ethics Education.” To learn more about Haddad’s research click to read more.
Brenda Coppard, PhD, OTR/L, FAOTABrenda Coppard, PhD, OTR/L, FAOTA, professor in the Department of Occupational Therapy and associate dean in the Office of Assessment, has been selected as an American Council on Education Faculty evaluator. An ACE evaluation is a rigorous, hands-on process conducted by a team of teaching faculty from relevant academic disciplines, representing a diversity of colleges and universities. The team assesses and validates whether courses, occupations, or professional examinations have the appropriate content, score, and rigor for college credit recommendations that may be eligible for academic transfers. To learn more about faculty evaluators, click here.
Chris Bradberry, PharmDThe Robert B. Daugherty Foundation, and Chris Bradberry, PharmD, dean of the School of Pharmacy and Health Professions helped secure a High Sensitivity LC/MS/MS instrument for all Creighton University researchers to use in Criss III, room 361. Among the many analytical instruments that researchers use for quantification of pharmaceuticals/nutraceuticals/drugs in different matrices LC-MS-MS stands as a most sensitive instrument. There are different types of mass spectrometers available in the market, quadrupole, TOF, Trap, ICR, Tandem and Hybrid. Selecting an appropriate mass spectrometer depends on the application. This means the instrument must be selected based on objectives, such as whether high sensitivity required or high resolution required. The main application of this instrument is to identify structure of a compound and quantitation of drugs and metabolites. Drug metabolism and pharmacokinetics in preclinical phase is the barrier to clinical studies of a lead candidate after in-vitro efficacy studies. LC-MS-MS is the only tool used for metabolite identification in absorption, distribution, metabolism and excretion (ADME). The majority of the investigational new drugs are potent, which demands quantification of drug and metabolite concentrations in picogram levels. Quantification at picogram level in biological matrices is challenging with the low/moderately-sensitive instruments (e.g., high-pressure liquid chromatography, HPLC) that are currently available to Creighton researchers.